Pular para o conteúdo
Merck
  • Loss of ATRX, associated with DNA methylation pattern of chromosome end, impacted biological behaviors of astrocytic tumors.

Loss of ATRX, associated with DNA methylation pattern of chromosome end, impacted biological behaviors of astrocytic tumors.

Oncotarget (2015-05-15)
Jinquan Cai, Jing Chen, Wei Zhang, Pei Yang, Chuanbao Zhang, Mingyang Li, Kun Yao, Hongjun Wang, Qingbin Li, Chuanlu Jiang, Tao Jiang
RESUMO

Loss of ATRX leads to epigenetic alterations, including abnormal levels of DNA methylation at repetitive elements such as telomeres in murine cells. We conducted an extensive DNA methylation and mRNA expression profile study on a cohort of 82 patients with astrocytic tumors to study whether ATRX expression was associated with DNA methylation level in astrocytic tumors and in which cellular functions it participated. We observed that astrocytic tumors with lower ATRX expression harbored higher DNA methylation level at chromatin end and astrocytic tumors with ATRX-low had distinct gene expression profile and DNA methylation profile compared with ATRX-high tumors. Then, we uncovered that several ATRX associated biological functions in the DNA methylation and mRNA expression profile (GEP), including apoptotic process, DNA-dependent positive regulation of transcription, chromatin modification, and observed that ATRX expression was companied by MGMT methylation and expression. We also found that loss of ATRX caused by siRNA induced apoptotic cells increasing, reduced tumor cell proliferation and repressed the cell migration in glioma cells. Our results showed ATRX-related regulatory functions of the combined profiles from DNA methylation and mRNA expression in astrocytic tumors, and delineated that loss of ATRX impacted biological behaviors of astrocytic tumor cells, providing important resources for future dissection of ATRX role in glioma.

MATERIAIS
Número do produto
Marca
Descrição do produto

Sigma-Aldrich
Dodecilsulfato de sódio, BioReagent, suitable for electrophoresis, for molecular biology, ≥98.5% (GC)
Sigma-Aldrich
Dodecilsulfato de sódio, ≥99.0% (GC), dust-free pellets
Sigma-Aldrich
Dodecilsulfato de sódio, BioUltra, for molecular biology, 10% in H2O
Sigma-Aldrich
Dodecilsulfato de sódio, ACS reagent, ≥99.0%
Sigma-Aldrich
Dodecilsulfato de sódio, BioUltra, for molecular biology, 20% in H2O
Sigma-Aldrich
Dodecilsulfato de sódio, ReagentPlus®, ≥98.5% (GC)
Sigma-Aldrich
Dodecilsulfato de sódio, BioUltra, for molecular biology, ≥99.0% (GC)
Supelco
Dodecilsulfato de sódio, dust-free pellets, suitable for electrophoresis, for molecular biology, ≥99.0% (GC)
Sigma-Aldrich
Dodecilsulfato de sódio, BioXtra, ≥99.0% (GC)
Sigma-Aldrich
Dodecilsulfato de sódio, ≥98.0% (GC)
Sigma-Aldrich
Dodecilsulfato de sódio, 92.5-100.5% based on total alkyl sulfate content basis
Sigma-Aldrich
Dodecilsulfato de sódio, tested according to NF, mixture of sodium alkyl sulfates consisting mainly of sodium dodecyl sulfate
Sigma-Aldrich
Dodecilsulfato de sódio, ≥90% ((Assay))
Sigma-Aldrich
Dodecilsulfato de sódio, BioReagent, suitable for electrophoresis, for molecular biology, ≥98.5% (GC), free-flowing, Redi-Dri
Sigma-Aldrich
MISSION® esiRNA, targeting human ATRX
Sigma-Aldrich
MISSION® esiRNA, targeting mouse Atrx